SCHEMBL4039396

SCHEMBL4039396

N#Cc1c(C(N)=O)c2n(c1C(F)(F)F)CCNC2OC(=O)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4042314 0.82 CSNK1E (0.33) —
SCHEMBL4037874 0.74 — —
Trifluoroacetic Acid SCHEMBL4039390 0.70 HTR2A (0.32) —
SCHEMBL4036480 0.69 CSNK1E (0.31) —
SCHEMBL4042066 0.68 — —
SCHEMBL4044863 0.65 SCN9A (0.34) —
Trifluoroacetic Acid SCHEMBL4038370 0.61 CSNK1E (0.36) —
SCHEMBL6421096 0.58 HTR3A (0.35) —
SCHEMBL20541071 0.57 KDM4E (0.34) —
SCHEMBL13964438 0.57 CSNK1E (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1436291-B1 INDOLIZINES AS KINASE PROTEIN INHIBITORS AVENTIS PHARMA SA (FR) 2009-01-14 — — EP disclosed
US-20070238734-A1 JNK INHIBITORS SANOLI-AVENTIS (FR) 2007-10-11 — — US disclosed
US-7148215-B2 Prodrugs as antihistamines or anticarcinogenic agents AVENTIS PHARMA S.A. (FR) 2006-12-12 — — US disclosed
US-20050009831-A1 Pyrrolo[1,2-a]pyrazine-8-carboxamides are JNK inhibitors, useful as anticarcinogenic agents AVENTIS PHARMA S.A, (FR) 2005-01-13 — — US disclosed
Send feedback